Optimization of Antisense Oligonucleotide Drugs for Skipping Dystrophin Exon 51 and 53 in Duchenne Muscular Dystrophy

被引：0
|
作者：
Wu, Bo [1 ]
机构：
[1] Carolinas Med Ctr, Charlotte, NC 28203 USA
来源：
MOLECULAR THERAPY | 2018年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
315
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [1] Optimization of Antisense Oligonucleotide for Skipping Human Dystrophin exon 45, 51 and 53 in Duchenne Muscular Dystrophy Patient-Derived Fibroblasts
    Wu, Bo
    Shah, Sapana N.
    Lu, Peijuan
    Lavigne, Jenifer L.
    Sparks, Susan
    Harper, Amy D.
    Lu, Qi Long
    MOLECULAR THERAPY, 2017, 25 (05) : 121 - 121
  • [2] Screening and Optimization of Antisense Oligonucleotide for Skipping Human Dystrophin Exon 51 and 53
    Wu, Bo
    Lu, Peijuan
    Shah, Sapana N.
    Milazi, Stephanie
    Bollinger, Lauren E.
    Lu, Qi Long
    MOLECULAR THERAPY, 2015, 23 : S60 - S60
  • [3] Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy
    Echigoya, Yusuke
    Lim, Kenji Rowel Q.
    Trieu, Nhu
    Bao, Bo
    Nichols, Bailey Miskew
    Vila, Maria Candida
    Novak, James S.
    Hara, Yuko
    Lee, Joshua
    Touznik, Aleksander
    Mamchaoui, Kamel
    Aoki, Yoshitsugu
    Takeda, Shin'ichi
    Nagaraju, Kanneboyina
    Mouly, Vincent
    Maruyama, Rika
    Duddy, William
    Yokota, Toshifumi
    MOLECULAR THERAPY, 2017, 25 (11) : 2561 - 2572
  • [4] Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy
    Takeshima, Y
    Yagi, M
    Wada, H
    Ishibashi, K
    Nishiyama, A
    Kakumoto, M
    Sakaeda, T
    Saura, R
    Okumura, K
    Matsuo, M
    PEDIATRIC RESEARCH, 2006, 59 (05) : 690 - 694
  • [5] Intravenous Infusion of an Antisense Oligonucleotide Results in Exon Skipping in Muscle Dystrophin mRNA of Duchenne Muscular Dystrophy
    Yasuhiro Takeshima
    Mariko Yagi
    Hiroko Wada
    Kazuto Ishibashi
    Atsushi Nishiyama
    Mikio Kakumoto
    Toshiyuki Sakaeda
    Ryuichi Saura
    Katsuhiko Okumura
    Masafumi Matsuo
    Pediatric Research, 2006, 59 : 690 - 694
  • [6] Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular Dystrophy
    van Deutekom, Judith
    Beekman, Chantal
    Bijl, Suzanne
    Bosgra, Sieto
    van den Eijnde, Rani
    Franken, Dennis
    Groenendaal, Bas
    Harquouli, Bouchra
    Janson, Anneke
    Koevoets, Paul
    Mulder, Melissa
    Muilwijk, Daan
    Peterburgska, Galyna
    Querido, Bianca
    Testerink, Janwillem
    Verheul, Ruurd
    de Visser, Peter
    Weij, Rudie
    Aartsma-Rus, Annemieke
    Puolivali, Jukka
    Bragge, Timo
    O'Neill, Charles
    Datson, Nicole A.
    NUCLEIC ACID THERAPEUTICS, 2023, 33 (03) : 193 - 208
  • [7] Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy
    Kasia Dzierlega
    Toshifumi Yokota
    Gene Therapy, 2020, 27 : 407 - 416
  • [8] Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy
    Dzierlega, Kasia
    Yokota, Toshifumi
    GENE THERAPY, 2020, 27 (09) : 407 - 416
  • [9] Antisense oligonucleotide design for therapeutic antisense-mediated exon skipping for Duchenne muscular dystrophy
    Aartsma-Rus, A.
    de Winter, C. L.
    Kaman, W. E.
    Janson, A. A. M.
    van Deutekom, J. C. T.
    NEUROMUSCULAR DISORDERS, 2006, 16 (9-10) : 686 - 686
  • [10] Exon skipping therapy for Duchenne muscular dystrophy - it takes more than an antisense oligonucleotide
    Aartsma-Rus, Annemieke
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
12345